An exosome-based liquid biopsy predicts depth of response and survival outcomes to cetuximab and panitumumab in metastatic colorectal cancer: The EXONERATE Study. - Xu C; Mannucci A; Esposito F; Oliveres H; Alonso Orduña V; Yubero A; Fernández-Martos C; Salud A; Gallego J; Martin-Richard M; Fernández-Plana J; Guillot M; et al. (Clinical Cancer Research, 2025)